Geode Capital Management, LLC Nrx Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Nrx Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 419,954 shares of NRXP stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
419,954
Previous 411,922
1.95%
Holding current value
$1.09 Million
Previous $189,000
4.23%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NRXP
# of Institutions
34Shares Held
3.74MCall Options Held
64.6KPut Options Held
9.6K-
Vanguard Group Inc Valley Forge, PA1.44MShares$3.74 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD615KShares$1.6 Million0.05% of portfolio
-
Black Rock Inc. New York, NY291KShares$755,8560.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny189KShares$490,8280.0% of portfolio
-
One Wealth Management Investment & Advisory Services, LLC Miami Beach, FL140KShares$365,0450.03% of portfolio
About NRX Pharmaceuticals, Inc.
- Ticker NRXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,641,296
- Market Cap $176M
- Description
- NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...